Clay Moseley
About Clay Moseley
Since its introduction to the market in 1998, LigaSure™ technology has set the industry standard for vessel sealing. The technology has been used in more than 4 million procedures worldwide, and is supported by an ever-growing body of evidence-based research, now totaling well over 200 published peer-reviewed studies. The clinical efficacy, consistency and reliability of LigaSure™ products is delivered through a variety of instruments for use in both laparoscopic and open procedures in a range of surgical specialties, including gynecological, colorectal, urology and general surgery. Across the range of products and procedures, LigaSure™ technology delivers a unique combination of pressure and energy to create a consistent seal with each application. •Provides a combination of pressure and energy to create vessel fusion •Permanently fuses vessels up to and including 7 mm in diameter and tissue bundles without dissection or isolation •Average seal cycle is 2 to 4 seconds* •Seals withstand three times normal systolic blood pressure •Feedback-controlled response system automatically discontinues energy delivery when the seal cycle is complete, eliminating the guesswork Before Covidien, my biggest test to date was when I launched an internet-based startup after graduating from college. My primary roles included selling the service and advertising space, developing the business plan, formulating proposals, and building relationships with prospective clients. I was successful in marketing and selling the service, and we launched our website with the most popular establishment in Wilmington, NC. Unfortunately, the downturn in the economy coincided with our start-up and we were forced to dissolve the company in November of last year. Nonetheless, the experience was PRICELESS. Specialties: Sales, surgical devices, surgical procedures, proposal/RFP development, salesforce.com, presentation skills, email marketing, integration of email and social media, copywriting